Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Sirona Biochem Corp
V.SBM
Alternate Symbol(s):
SRBCF
Healthcare
Biotechnology
Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with a proprietary technology platform developed at its laboratory facility in France with a specialization in the stabilization of carbohydrate molecules. The Company is exploring the areas of diabetes, dyschromia, anti-aging, anti-cellulite and antiviral therapies and relies on a business model of licensing patents to...
large organizations in return for up-front and milestone payments as well as royalties. Its two most advanced programs are the cosmetic skin lightener and diabetes drug. The Company's TFC-1067 is for the treatment of Dyschromia (Dark spots on the skin). GlycoProteMim is a novel anti-aging compound. GlycoProteMim is based on the naturally occurring glycoproteins found in Antarctic fish, known to protect them against environmental stressors. It is focused on three current antiviral categories: Neuraminidase Inhibitors, Nucleoside Analogs and Iminosugars. Its wholly owned subsidiary is TFChem S.A.R.L.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (TSXV:SBM)
New Post
View:
Posts & Comments
Threaded Posts
Prev
...
121
122
123
124
125
126
127
128
129
130
131
132
133
134
135
136
137
138
139
140
...
Next
(33)
•••
SleepyHoward
X
View Profile
View Bullboard History
Post by
SleepyHoward
on Jul 03, 2023 10:21am
Worst management ever
The volume is the result of the management they are posion for shareholders and TFChem
(10)
•••
PeterG
X
View Profile
View Bullboard History
Comment by
PeterG
on Jul 03, 2023 10:13am
RE:Are the anti aging results not worth talking about?
Well, Howard has recognised that only hard facts count. So just a bloody news as" several big parties reached out to Sirona" will not boost the share price anymore. 2019 is over!!
Level Up Your Trading with BMO InvestorLine’s Enhanced Features
posted Nov 24, 2024 9:00am by
Bank of Montreal
-
|
Features like Multi-Leg Orders, Options Screener, and Strategy Builder will be particularly exciting for traders. They have been designed to be intuitive and user-friendly, regardless of your experience level. Whether you’re a seasoned pro or just starting out, you’ll find these tools easy to navigate and adapt to your investing style. ...read more
(38)
•••
Turtle4
X
View Profile
View Bullboard History
Post by
Turtle4
on Jul 03, 2023 8:02am
Are the anti aging results not worth talking about?
I find it amazing how Sirona manages to keep the results of the anti-aging study secret. Except for the publication on the homepage and the paid interview with Geraldine, nothing has leaked out. I don
...more
(1183)
•••
navajojoe
X
View Profile
View Bullboard History
Comment by
navajojoe
on Jul 02, 2023 10:08am
RE:RE:RE:RE:RE:RE:Financials out last night
I can't believe SBM can't even launch one successful product.
(10)
•••
PeterG
X
View Profile
View Bullboard History
Comment by
PeterG
on Jul 02, 2023 9:37am
RE:RE:RE:RE:RE:Financials out last night
Can't believe that Allergan launchs two products with the same treatment within one year. I'm January, tney already launched Even &Correct collection.
(1167)
•••
Pandora
X
View Profile
View Bullboard History
Comment by
Pandora
on Jul 01, 2023 11:41am
RE:RE:RE:RE:RE:RE:RE:Financials out last night
Whoops, that should be the 28th, not the 25th.
(11)
•••
Transperance
X
View Profile
View Bullboard History
Comment by
Transperance
on Jul 01, 2023 11:40am
RE:RE:RE:RE:RE:Financials out last night
Thanks for your comments on the financial reporting.It will be interesting to follow the financials going forward. After a significant uptick in revenue in the July 2022 quarter when the Abbvie deal
...more
(1167)
•••
Pandora
X
View Profile
View Bullboard History
Comment by
Pandora
on Jul 01, 2023 11:33am
RE:RE:RE:RE:RE:RE:Financials out last night
Trading volumes have not been great, in fact pathetic, in some cases. Over the past couple of weeks some days don't even register - like yesterday and the 25th: Date
...more
(1183)
•••
navajojoe
X
View Profile
View Bullboard History
Comment by
navajojoe
on Jul 01, 2023 9:32am
RE:RE:RE:RE:RE:Financials out last night
All we can do is sit back and hope and pray that this isn't another R&F fiasco. If Abbvie comes through, we are off to the races.
(75)
•••
forhandlaren
X
View Profile
View Bullboard History
Comment by
forhandlaren
on Jul 01, 2023 3:52am
RE:RE:RE:RE:Financials out last night
Let's assume that 59,514 CAD refers to sales to Abbvie. The financials ended April 23 which means that the compund should have been delivered not later than March. The amount indicates that it'
...more
(101)
•••
biorun
X
View Profile
View Bullboard History
Comment by
biorun
on Jun 30, 2023 10:07pm
RE:RE:RE:Financials out last night
Sales to R&F ceased some time ago. So that would mean that AbbVie is now paying for raw product which will go into the distribution at some point if in fact this chart column title is from the
...more
(2138)
•••
lscfa
X
View Profile
View Bullboard History
Comment by
lscfa
on Jun 30, 2023 3:47pm
RE:RE:Financials out last night
Qtr ending Milestone Payment Sales to RF/Abbvie Other Total Revenue Apr 23
...more
(2138)
•••
lscfa
X
View Profile
View Bullboard History
Comment by
lscfa
on Jun 30, 2023 3:45pm
RE:Financials out last night
Fins show revenue for qtr ended Apr 2022 as $190,923 which is wrong. The correct no. is zero. The $190,923 number is for qtr ended Apr 2021 ! ! ! --- Fire the part time CFO ---
(2138)
•••
lscfa
X
View Profile
View Bullboard History
Comment by
lscfa
on Jun 30, 2023 3:38pm
RE:Financials out last night
$59,514 in revenues, no bloody explanation. Worst MD&A's on the TSXV.
Prev
...
121
122
123
124
125
126
127
128
129
130
131
132
133
134
135
136
137
138
139
140
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >